Brain tissue removed during surgery reveals potential way to curb inflammation linked to Alzheimer's
· Medical Xpressedited by Gaby Clark, reviewed by Robert Egan
Gaby Clark
Scientific Editor
Meet our editorial team
Behind our editorial process
Robert Egan
Senior Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
peer-reviewed publication
trusted source
proofread
The GIST Add as preferred source
Inflammatory conditions in the brain, including traumatic brain injury and degenerative diseases like Alzheimer's, could be targeted with an existing drug thanks to new research that shows it can work in brain cells.
In a study published in Brain, a team led by professor Nicholas Barnes at the University of Birmingham has identified a critical receptor that, when blocked, inhibits neuroinflammation. This first-of-its-kind work with human brain tissue demonstrates how interrupting this pathway could open the door to treating a wide spectrum of chronic neurological conditions. These include not only traumatic brain injury (TBI) but also neurodegenerative diseases such as Alzheimer's and Parkinson's disease, and even psychiatric disorders such as depression and psychosis. These latter conditions are increasingly understood to have a neuroinflammatory component.
Using live cultures of human brain cells and slices of brain tissue obtained during neurosurgery, the researchers investigated the role of a receptor known as the P2X7 receptor, which is responsible for triggering inflammatory signaling.
Their findings reveal that these P2X7 receptors drive the release of key proteins called cytokines involved in controlling inflammation. By blocking this receptor with a specific antagonist, the team was able to significantly reduce the inflammatory response in human brain tissue.
Barnes, from the College of Medicine and Health at the University of Birmingham and the paper's corresponding author, said, "This exciting discovery marks a major step toward repurposing existing therapeutics to combat neuroinflammation at its source. The identification of this receptor could have far-reaching implications for some of the most debilitating and widespread brain disorders such as Alzheimer's disease, Parkinson's and multiple sclerosis, or inflammation-linked psychiatric conditions like schizophrenia and depression."
Brain's resident immune sentinels
To study how brain cells respond to and manage inflammation, the team developed a way of turning a type of white blood cell into microglia, replicating a normal cellular transformation recently identified as occurring in the brain as a natural part of human aging. These microglia are the central coordinators of the immune system in the brain.
The researchers converted readily accessible human peripheral monocytes taken from blood samples into microglia-like cells that were used to see how microglia are likely to respond to inflammation signals. Using the P2X7 receptor antagonist, the team was then able to interrupt the triggers that these microglia give off as they are damaged and die.
Barnes said, "Studying human microglia has long been a major challenge: once removed from their native brain environment, they rapidly lose their defining characteristics, likely due to the absence of critical regulatory signals. Our approach involved the use of monocyte-derived microglia, which provide a powerful, scalable and virtually unlimited platform for studying human microglial biology with unprecedented precision.
"The response identified in the human monocyte-derived microglia provided the impetus to translate these findings to human brain tissue obtained following neurosurgical procedures. This successful translation means the next stage for this research is the development of clinical trials in patients with neurodegenerative conditions and patients with TBI, for whom there are no effective pharmacological treatments to reduce neuroinflammation and the resulting damage."
Publication details
Jamie Cowley et al, P2X7R-mediated IL-1β release by human brain tissue: the impact of CNS-penetrant potential therapeutics, Brain (2026). DOI: 10.1093/brain/awag068
Journal information: Brain
Key medical concepts
Clinical categories
NeurologyClinical pharmacology Provided by University of Birmingham Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Robert Egan
Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →
Citation: Brain tissue removed during surgery reveals potential way to curb inflammation linked to Alzheimer's (2026, October 4) retrieved 5 October 2026 from https://medicalxpress.com/news/2026-10-brain-tissue-surgery-reveals-potential.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.